“..lab automation development collaboration within the bioanalytical industry will benefit every party and is necessary, justifiable and feasible.”
By now there should have been a consensus [1–3] in the bioanalytical industry that automation in bioanalytical laboratories improves sample throughput and data integrity, shortens method development time [4,5] and sample data turnaround time. In addition, automation reduces tedious labor, occupational hazards, employee turnover and, in general, improves productivity. These factors all lead to benefits in drug development timelines and costing [1–3]. Currently in bioanalysis, the bottleneck is mostly with the wet chemistry/sample preparation portion of the workflow, be it either sample preparation method development or sample preparation for routine analysis .
Click here to view the full article.